ClinicalTrials.govpublic full text
Escitalopram and the Risk of Serious Adverse Events
chronic kidney disease (ckd), elderly, outpatient, chronic kidney disease, high-throughput computing, drug adverse events, selective serotonin reuptake inhibitors, escitalopram, geriatrics, drug safety, observational
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 805746
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.